2
Views
3
CrossRef citations to date
0
Altmetric
Original Article

HIV-1 Reverse Transcriptase Variants: Molecular Modeling of Y181C, V106A, L100I, and K103N Mutations with Nonnucleoside Inhibitors Using Monte Carlo Simulations in Combination with a Linear Response Method

, , , , , , , , , , , & show all
Pages 151-163 | Published online: 04 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

María Javiera Alvarez-Figueroa, Carlos David Pessoa-Mahana & Daniela Andrea González-Bustamante. (2008) Influence of Lipophilia and of the Vehicle Used in the Transdermal Absorption of Novel Benzimidazole Compounds with Possible Anti-HIV Activity. Pharmaceutical Development and Technology 13:2, pages 127-133.
Read now

Articles from other publishers (2)

Silvana Opp, Thomas Fricke, Caitlin Shepard, Dmytro Kovalskyy, Akash Bhattacharya, Frank Herkules, Dmitri N. Ivanov, Baek Kim, Jose Valle-Casuso & Felipe Diaz-Griffero. (2017) The small-molecule 3G11 inhibits HIV-1 reverse transcription. Chemical Biology & Drug Design 89:4, pages 608-618.
Crossref
Reynel Cancio, Romano Silvestri, Rino Ragno, Marino Artico, Gabriella De Martino, Giuseppe La Regina, Emmanuele Crespan, Samantha Zanoli, Ulrich Hübscher, Silvio Spadari & Giovanni Maga. (2005) High Potency of Indolyl Aryl Sulfone Nonnucleoside Inhibitors towards Drug-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutants Is Due to Selective Targeting of Different Mechanistic Forms of the Enzyme. Antimicrobial Agents and Chemotherapy 49:11, pages 4546-4554.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.